A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale
暂无分享,去创建一个
Tyrone D. Cannon | D. Mathalon | S. Woods | P. McGuire | R. Keefe | S. Ruhrmann | M. Sand | D. Cotton | D. Roy | H. Rosenbrock | K. Daniels | S. Pollentier | S. Woods